Lectures

Earning CPD by listening to Healthed podcasts is simple. Each episode is eligible for Educational Activities CPD.

Filter results

0.5 EA

The evidence for the effectiveness of new drug options for chronic disease will be discussed, including when, how and in whom they should be prescribed to.

0.5 EA

This lecture equips GPs with practical updates on IPD vaccination - who, when, which vaccine, funding, and high-risk patient groups.

0.5 EA

Dr Ted Wu discussed the opportunities and challenges that future research into cardiovascular outcomes in patients with type 2 diabetes are likely to encounter.

Expert/s: Dr Ted Wu
0.5 EA

This presentation discuss the risk of nutritional deficits and loss of muscle mass associated with the use of GLP-1 receptor agonists and recommendations on how to reduce these risks.

0.5 EA

Changes to the Australian prostate cancer screening guidelines will be discussed including the updated risk: benefit profile for PSA testing, who should be tested and how test results should be interpreted and managed.

Dr Alison Chiu provides an update on the pathophysiology of dry eye and who is at risk of developing this condition.

Expert/s: Dr Alison Chiu
0.5 EA

A/Prof Martin McDonald outlines the role of LAMAs in the treatment of asthma.

0.5 EA

Dr Julia Crawford discusses red flags to look out for when assessing a patient presenting with a head or neck lump.

0.5 EA

A/Prof Mark Yates describes the interaction between dementia and comorbidities.

0.5 EA

A/Prof Nicole Goh discusses the current state of play of the screening program.

0.5 EA

Dr Kate Walsh provides an update on the latest, best-practice management of endometriosis in primary care.

Expert/s: Dr Kate Walsh
0.5 EA

Prof Finlay Macrae AO discusses how GPs can suspect, assess and manage hereditary colorectal cancer risk.

The evidence for the effectiveness of new drug options for chronic disease will be discussed, including when, how and in whom they should be prescribed to.

This lecture equips GPs with practical updates on IPD vaccination - who, when, which vaccine, funding, and high-risk patient groups.

Dr Ted Wu discussed the opportunities and challenges that future research into cardiovascular outcomes in patients with type 2 diabetes are likely to encounter.

Expert/s: Dr Ted Wu

This presentation discuss the risk of nutritional deficits and loss of muscle mass associated with the use of GLP-1 receptor agonists and recommendations on how to reduce these risks.

Changes to the Australian prostate cancer screening guidelines will be discussed including the updated risk: benefit profile for PSA testing, who should be tested and how test results should be interpreted and managed.

Dr Alison Chiu provides an update on the pathophysiology of dry eye and who is at risk of developing this condition.

Expert/s: Dr Alison Chiu

A/Prof Martin McDonald outlines the role of LAMAs in the treatment of asthma.

Dr Julia Crawford discusses red flags to look out for when assessing a patient presenting with a head or neck lump.

A/Prof Mark Yates describes the interaction between dementia and comorbidities.

A/Prof Nicole Goh discusses the current state of play of the screening program.

Dr Kate Walsh provides an update on the latest, best-practice management of endometriosis in primary care.

Expert/s: Dr Kate Walsh

Prof Finlay Macrae AO discusses how GPs can suspect, assess and manage hereditary colorectal cancer risk.

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.